Item 8.01. Other Events.
On July 26, 2022, Global Blood Therapeutics, Inc. issued a press release titled
"MHRA Grants Marketing Authorization for GBT's Oxbryta® (voxelotor) for Use in
Great Britain for the Treatment of Hemolytic Anemia in Patients with Sickle Cell
Disease Age 12 Years and Older." A copy of the press release is attached as
Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by
reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number Description
99.1 Press Release dated July 26, 2022
104 Cover Page Interactive Data File (embedded within the Inline
XBRL document)
© Edgar Online, source Glimpses